KalVista Pharmaceuticals Inc. logo

KalVista Pharmaceuticals Inc. (4XC1)

Market Open
8 Dec, 06:36
13. 90
+1.8
+14.88%
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
-2.92 Eps
12.1
Previous Close
Day Range
13.8 13.9
Year Range
7.1 13.9
Want to track 4XC1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 3 days
KalVista Pharmaceuticals Inc. logo
4XC1 KalVista Pharmaceuticals Inc.
11 Dec 2025 (In 3 days)
-
Cons. EPS
-
EPS
KalVista Pharmaceuticals Inc. logo
4XC1 KalVista Pharmaceuticals Inc.
3 Dec 2025
-
Cons. EPS
-
EPS
KalVista Pharmaceuticals Inc. logo
4XC1 KalVista Pharmaceuticals Inc.
3 Sep 2025
-
Cons. EPS
-
EPS
KalVista Pharmaceuticals Inc. logo
4XC1 KalVista Pharmaceuticals Inc.
10 Jul 2025
-
Cons. EPS
-
EPS
KalVista Pharmaceuticals Inc. logo
4XC1 KalVista Pharmaceuticals Inc.
10 Mar 2025
-
Cons. EPS
-
EPS
KalVista Pharmaceuticals Inc. logo
4XC1 KalVista Pharmaceuticals Inc.
5 Dec 2024
-
Cons. EPS
-
EPS
KalVista Pharmaceuticals Inc. logo
4XC1 KalVista Pharmaceuticals Inc.
5 Sep 2024
-
Cons. EPS
-
EPS
KalVista Pharmaceuticals Inc. logo
4XC1 KalVista Pharmaceuticals Inc.
5 Jul 2024
-
Cons. EPS
-
EPS
KalVista Pharmaceuticals Inc. logo
4XC1 KalVista Pharmaceuticals Inc.
7 Mar 2024
-
Cons. EPS
-
EPS
KalVista Pharmaceuticals Inc. logo
4XC1 KalVista Pharmaceuticals Inc.
6 Dec 2023
-
Cons. EPS
-
EPS

4XC1 Earnings Reports FAQ

What is the earnings per share (EPS) for 4XC1?

The current EPS is -2.92.

What is the company's earnings growth rate?

KalVista Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2025-12-11, based on the 4XC1's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for KalVista Pharmaceuticals Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 4XC1 at this time, as KalVista Pharmaceuticals Inc has no recent EPS data to calculate it.